News

A team led by Dr Chuck Bailey at the Centenary Institute has been awarded a National Health and Medical Research Council (NHMRC) Ideas Grant to develop safer and more effective gene therapies.

Dr Felix Marsh-Wakefield, from the Centenary Institute’s Centre for Cancer Innovations and the University of Sydney, has been interviewed on the 2GB Healthy Living program.

The Centenary Institute has signed a Memorandum of Understanding (MOU) with Guangzhou Medical University, one of China's leading institutions renowned for its pioneering research in respiratory diseases, oncology and infectious diseases.

The Centenary Institute has received important funding from the RT Hall Trust to bolster two ground-breaking cancer research initiatives. Almost one in two Australians will be diagnosed with cancer by the age of 85. Cancer is a leading cause of death, claiming around 50,000 Australians annually.

Associate Professor Guy Lyons, a Laboratory Head at the Centenary Institute’s Centre for Cancer Innovations, has been awarded the prestigious Barry Preston Award by the Matrix Biology Society of Australia & New Zealand.

New research from the Centenary Institute and the University of Sydney has uncovered important insights into the immune environment within liver cancer, the sixth most common cancer worldwide and the third leading cause of cancer-related deaths.

Centenary Institute researcher Dr Alex Cole has been awarded a $100,000 Ramaciotti Health Investment Grant to support his research into improving the safety and precision of gene therapy treatments.

The Centenary Institute recently brought its striking ‘When Art Meets Science’ exhibition to Government House, where hundreds of visitors were able to witness a remarkable fusion between art and life-saving medical research. Stunning images captured by Centenary Institute researchers during their pioneering work, were displayed as part of the Government House Jazz@theHouse event, an afternoon ...

Dr Mark Schreuder, a researcher at the Centenary Institute’s Centre for Cancer Innovations, has received the Kenyon Foundation Inflammation Award for 2024.

New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalised approaches to preventing and managing type 2 diabetes.

An international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at risk of developing alcohol-associated cirrhosis, a severe form of liver disease.

The Centenary Institute has announced the winners of its ‘When Art Meets Science’ scientific image prize. The annual prize celebrates the artistic masterpieces captured by Centenary Institute researchers in the course of their ground-breaking medical research.